Bain Capital Private Equity brings extensive experience and resources to help management teams assess and capitalize on business opportunities. Since 1984, we have completed over 280 investments across a broad array of investment types, business life cycle, industries and geographies.


Regions: Asia Pacific Industry: healthcare Year: 2017

Hugel is a publicly traded biopharmaceutical company in Korea that primarily focuses on the manufacturing and selling of botulinum toxin (BTX – widely known as Botox) and hyaluronic acid dermal fillers (HA Fillers).

view company website »